Douglas Miehm
Stock Analyst at RBC Capital
(3.90)
# 1,805
Out of 4,455 analysts
389
Total ratings
49.8%
Success rate
5%
Average return
Main Sectors:
Stocks Rated by Douglas Miehm
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: DHT.UN DRI Healthcare Trust | Maintained: Buy | $21.00 | $17.45 | +20.34% | 41 | May 15, 2026 | |
| TSX: DR Medical Facilities Corporation | Maintained: Hold | $17.00 → $19.00 | $18.00 | +5.56% | 46 | May 10, 2026 | |
| TSX: WELL WELL Health Technologies Corp. | Reiterated: Buy | $7.00 | $4.13 | +69.49% | 22 | May 10, 2026 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Hold | $15 | $17.23 | -12.94% | 43 | May 8, 2026 | |
| TSX: GUD Knight Therapeutics Inc. | Maintained: Buy | $8.50 → $9.50 | $9.45 | +0.53% | 27 | May 8, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $235 → $262 | $303.59 | -13.70% | 16 | May 7, 2026 | |
| MNKD MannKind | Maintained: Hold | $3.5 → $4.75 | $4.14 | +14.73% | 8 | May 7, 2026 | |
| PCRX Pacira BioSciences | Maintained: Hold | $22 → $24 | $25.24 | -4.91% | 5 | Apr 30, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | $12.81 | $6.77 | +89.27% | 102 | Apr 30, 2026 | |
| BLCO Bausch + Lomb | Maintained: Buy | $21 | $16.32 | +28.68% | 36 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.73 | $14.75 | -47.62% | 1 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.46 → $3.5 | $0.9478 | +269.28% | 30 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $19 | $4.64 | n/a | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €22.00 | $84.50 | n/a | 3 | Jun 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $6.02 | n/a | 6 | Aug 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $2.96 | n/a | 1 | Feb 5, 2009 |
DRI Healthcare Trust
May 15, 2026
Maintained: Buy
Price Target: $21.00
Current: $17.45
Upside: +20.34%
Medical Facilities Corporation
May 10, 2026
Maintained: Hold
Price Target: $17.00 → $19.00
Current: $18.00
Upside: +5.56%
WELL Health Technologies Corp.
May 10, 2026
Reiterated: Buy
Price Target: $7.00
Current: $4.13
Upside: +69.49%
Aurinia Pharmaceuticals
May 8, 2026
Reiterated: Hold
Price Target: $15
Current: $17.23
Upside: -12.94%
Knight Therapeutics Inc.
May 8, 2026
Maintained: Buy
Price Target: $8.50 → $9.50
Current: $9.45
Upside: +0.53%
Ligand Pharmaceuticals
May 7, 2026
Reiterated: Buy
Price Target: $235 → $262
Current: $303.59
Upside: -13.70%
MannKind
May 7, 2026
Maintained: Hold
Price Target: $3.5 → $4.75
Current: $4.14
Upside: +14.73%
Pacira BioSciences
Apr 30, 2026
Maintained: Hold
Price Target: $22 → $24
Current: $25.24
Upside: -4.91%
Bausch Health Companies Inc.
Apr 30, 2026
Maintained: Hold
Price Target: $12.81
Current: $6.77
Upside: +89.27%
Bausch + Lomb
Apr 30, 2026
Maintained: Buy
Price Target: $21
Current: $16.32
Upside: +28.68%
Mar 19, 2026
Maintained: Buy
Price Target: $7.73
Current: $14.75
Upside: -47.62%
Nov 19, 2025
Maintained: Buy
Price Target: $2.46 → $3.5
Current: $0.9478
Upside: +269.28%
Oct 8, 2021
Reiterated: Hold
Price Target: $18 → $19
Current: $4.64
Upside: n/a
Jun 23, 2021
Maintained: Buy
Price Target: €22.00
Current: $84.50
Upside: n/a
Aug 4, 2016
Reiterated: Hold
Price Target: $1
Current: $6.02
Upside: n/a
Feb 5, 2009
Upgraded: Buy
Price Target: n/a
Current: $2.96
Upside: n/a